20 (AIDX) Accounts Payables (2024 - 2026)

20 (AIDX) reported Accounts Payables of $980486.0 for Q1 2026, up 12.89% quarter-over-quarter from $868545.0 in Q4 2025.

20 (AIDX) Accounts Payables (2024 - 2026) Analysis & Trends

20 has reported Accounts Payables for 3 years, with the latest figure at $980486.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $980486.0; the trailing twelve-month figure through Mar 2026 stood at $980486.0 (changed N/A YoY), and the FY2025 full-year result was $868545.0, up 133.29% from the prior year.
  • Accounts Payables for Q1 2026 stood at $980486.0, up from $868545.0 in the prior quarter.
  • The five-year high for Accounts Payables was $980486.0 in Q1 2026, with the low at $372303.0 in Q4 2024.
  • Historically, Accounts Payables has averaged $740444.7 across 3 years, with a median of $868545.0 in 2025.
  • The largest YoY upside for Accounts Payables was 133.29% in 2025 against a maximum downside of 133.29% in 2025.
  • 20's Accounts Payables stood at $372303.0 in 2024, then soared by 133.29% to $868545.0 in 2025, then rose by 12.89% to $980486.0 in 2026.
  • The last three Accounts Payables figures came in at $980486.0 (Q1 2026), $868545.0 (Q4 2025), and $372303.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 4.68 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.59 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.33 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 3.41 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 338.80 Mn
10 20 - - 62,884.00 980,486.00

Historic Data

Download Data
DateValue
Mar 31, 2026 980,486.00
Dec 31, 2025 868,545.00
Dec 31, 2024 372,303.00